Dolutegravir discontinuation due to neuropsychiatric adverse events: a pharmacogenetic case-control study

De Greef, Julien

Dolutegravir discontinuation due to neuropsychiatric adverse events: a pharmacogenetic case-control study

De Greef, Julien

(2023) 19th European AIDS Conference (EACS) — Location: (Poland) Warsaw (18.October.2023)

Files

No attached file found for this publication.

Details

Authors

De Greef, JulienUCLouvain
Author

Affiliations

UCLouvainSSS/IREC/LTAP - Louvain Centre for Toxicology and Applied Pharmacology
UCLouvain(SLuc) Service de médecine interne et maladies infectieuses (MIMI)

Citations

APA
Chicago
FWB

De Greef, J. (2023). Dolutegravir discontinuation due to neuropsychiatric adverse events: a pharmacogenetic case-control study. 19th European AIDS Conference (EACS), (Poland) Warsaw. https://hdl.handle.net/2078.5/24356